Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

BACKGROUND: Premature discontinuation of aromatase inhibitors (AIs) in breast cancer survivors compromises treatment outcomes. We aimed to evaluate whether patient-reported joint pain predicts premature discontinuation of AIs. METHODS: We conducted a retrospective cohort study of postmenopausal wome...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chim, Kannie, Xie, Sharon X, Stricker, Carrie T, Li, Qing S, Gross, Robert, Farrar, John T, DeMichele, Angela, Mao, Jun J
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847371/
https://ncbi.nlm.nih.gov/pubmed/24004677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-401
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires